GU Cancer
Advertisement
Researchers are illuminating why clinical nurse specialists are "best placed to offer holistic care" for these patients.
A system based on two prognostic factors can predict the outcomes of these patients.
A quantitative-qualitative survey provided insights on patient experiences, emotions, and perceptions
Research presented at JADPRO Live provided insights into patient preferences surrounding treatment administration.
The study analyzed how decision making and quality of life contribute to treatment regret in patients with prostate cancer.
The integrative literature review evaluated clinician and patient experiences and outcomes for nurse-led flexible cystoscopy.
The multi-site, retrospective study assessed patients with advanced urothelial carcinoma and neuropathy or diabetes mellitus.
The first-of-its kind clinical trial was presented at the 2024 ASTRO Annual Meeting.
A team used an interpretive description approach to evaluate the self-management support intervention.
The study investigators say the 5-year survival rate "dramatically exceeds historical standards."
The personalized, stratified follow-up pathway is led by advanced nurse practitioners and general practitioners.
Learn what a team found when they implemented a pre-appointment electronic PRO measure for patients with prostate cancer.
A collaborative approach between nurses and caregivers may help improve quality of life in patients and caregivers.
The combination was evaluated in the phase II KEYNOTE-199 clinical trial, which included multiple cohorts.
The survey of oncology nurses identified 3 top areas of unmet needs of patients with GU cancers.
Learn how a team developed an online group cognitive rehabilitation program for survivors of prostate cancer.
The trial is the first to evaluate the combination of an ADC and a TKI in metastatic urothelial carcinoma.
Learn about a pilot study of a survivorship program that is currently enrolling men with advanced GU cancers.
The study showed that a certain starting dose of the ADC maximized the likelihood of response to treatment.
A new study evaluated how social determinants of health can affect the risk of death in patients with cancer.
Advertisement
630 Madison Ave.
Manalapan, NJ 07726
© 2024 Mashup Media, LLC, a Formedics Property. All Rights Reserved.